Q301

· Qurient Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Q301, covering 2016-12-06 to 2020-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of Q301 in Mild to Moderate Adolescents and Adults Atopic Dermatitis Patients [Phase 2]